Early diagnosis of brain tumours through biofluid metabolomics
Objectives: Over 20% of cancer patients develop brain metastases. Current MRI diagnostic techniques only detect late stage metastases, since they rely on blood-brain-barrier permeability to allow contrast enhancement. Thus, new methods enabling earlier diagnosis are urgently needed. We have previous...
Prif Awduron: | Larkin, J, Dickens, A, Claridge, T, Anthony, D, Sibson, N |
---|---|
Fformat: | Conference item |
Cyhoeddwyd: |
SAGE Publications
2016
|
Eitemau Tebyg
-
Early diagnosis of brain metastases through biofluid metabolomics
gan: Larkin, JR, et al.
Cyhoeddwyd: (2017) -
Early diagnosis of brain metastases using a biofluids-metabolomics approach in mice
gan: Larkin, J, et al.
Cyhoeddwyd: (2016) -
Biofluid analysis to differentiate brain disease
gan: Dickens, A, et al.
Cyhoeddwyd: (2012) -
NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.
gan: Dickens, A, et al.
Cyhoeddwyd: (2015) -
NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis
gan: Dickens, A, et al.
Cyhoeddwyd: (2015)